HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.
Journal article published in 2014 by
Alberto Ramírez,
Cynthia Morata-Tarifa,
Macarena Perán,
Houria Boulaiz,
Manuel Picon-Ruiz,
Gema Jiménez,
Ahmad Agil,
Ana Sánchez,
Olga Cruz-López,
Ana Conejo-García,
Joaquin M. Campos 
,
Maria A. García,
Juan Antonio Marchal
,
Maria A. García,
Juan Antonio Marchal
